Trial intelligence / Profile preview

ARTEGO Study

PACTR201710002665193Not yet recruiting

Sponsor
Kingsglaive Consultants
Start
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

Trial of artemisinin, naphthoquine, primaquine and lumefantrine in malaria and Malaria (2 arms), sponsored by Kingsglaive Consultants. Planned start Nov 2017; status: not yet recruiting.

02

Drugs

artemisininnaphthoquineprimaquinelumefantrine
03

Conditions

malariaMalaria

Beyond the preview

Go deeper on PACTR201710002665193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201710002665193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call